# Systematic Ambulatory ECG Monitoring Following TAVI

Study · id `cardio:ct-nct07739316` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07739316](<https://clinicaltrials.gov/study/NCT07739316>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07739316

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 754 participants.

## Technical summary

Registry record NCT07739316. Randomized; no masking; primary purpose treatment. Start 2026-10-23 (actual); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 754 participants (planned count; ClinicalTrials.gov record NCT07739316, source copy `cardio:ctgov-nct07739316-2026-11-04`, retrieved 2026-11-18)
- Started: 2026-10-23 (actual) (ClinicalTrials.gov record NCT07739316, source copy `cardio:ctgov-nct07739316-2026-11-04`, retrieved 2026-11-18)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07739316, source copy `cardio:ctgov-nct07739316-2026-11-04`, retrieved 2026-11-18)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07739316, source copy `cardio:ctgov-nct07739316-2026-11-04`, retrieved 2026-11-18)
- Countries: Canada (ClinicalTrials.gov record NCT07739316, source copy `cardio:ctgov-nct07739316-2026-11-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07739316-2026-11-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Systematic Ambulatory ECG Monitoring Following TAVI
- Acronym: RECORDII
- Condition: Aortic Stenosis
- Condition: Conduction Disturbances
- Intervention (Device): Ambulatory ECG monitoring
- Lead sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval (`cardio:org-institut-universitaire-de-cardiologie-et-de-pneumologie-de-ac9f54`)

## Provenance

Content hash: ba062848ec156eb9189fe9af4552b162fb3ee1907d81f0ffa9121820fd11393a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
